West Pharmaceutical Services
West Pharmaceutical Services, Inc., commonly referred to as West, is a leading provider of innovative solutions for injectable drug delivery and containment. Headquartered in the United States, West operates extensively across major regions, including Europe and Asia, serving a global clientele in the pharmaceutical and biotechnology industries. Founded in 1923, the company has achieved significant milestones, including advancements in drug delivery systems and the development of high-quality packaging solutions. West's core offerings include a range of primary packaging components, delivery systems, and contract manufacturing services, all designed to enhance the safety and efficacy of medications. What sets West apart is its commitment to quality and innovation, ensuring that its products meet the stringent demands of the healthcare sector. With a strong market position and a reputation for excellence, West continues to be a trusted partner for pharmaceutical companies worldwide.
DitchCarbon Score
How does West Pharmaceutical Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
West Pharmaceutical Services's score of 28 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
West Pharmaceutical Services's reported carbon emissions
In 2023, West Pharmaceutical Services reported total emissions of approximately 104,190,000 kg CO2e, encompassing Scope 1 and Scope 2 emissions. This figure reflects the company's ongoing commitment to reducing its carbon footprint. Notably, West Pharmaceutical Services has set ambitious targets to reduce absolute emissions by 40% for both Scope 1 and Scope 2 by the year 2030, starting from 2022. Historically, the company has shown a commitment to sustainability, with emissions in 2015 recorded at approximately 144,000,000 kg CO2e (26,493,000 kg CO2e for Scope 1 and 118,057,000 kg CO2e for Scope 2). By 2019, total emissions had decreased to about 122,178,000 kg CO2e, indicating progress in their reduction efforts. In addition to emissions reduction, West Pharmaceutical Services aims to achieve 50% renewable electricity usage and improve energy efficiency by 3% annually, further enhancing their climate commitments. The company is actively working towards these goals within the pharmaceutical, biotechnology, and life sciences sector, demonstrating a proactive approach to addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 26,493,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - |
| Scope 2 | 118,057,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - |
| Scope 3 | - | 00,000,000 | 00,000,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
West Pharmaceutical Services is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
